3 Compelling Reasons to Buy Novavax Right Now
There's an old investing adage: "Don't try to catch a falling knife." Novavax (NASDAQ: NVAX) fits the description of a falling knife right now. The biotech has lost nearly half of its market cap in just one month. That might discourage some investors from even considering buying shares.
However, I'd argue that Novavax should be more attractive to investors now than it has in quite a while. Here are three compelling reasons to buy the biotech stock.
Image source: Getty Images.
Source Fool.com
